Indeed, IDH-wild type gliomas often amplify epidermal growth factor receptor (EGFR), gain of chromosome 7 and loss of chromosome 10 and telomerase reverse transcriptase (TERT) promoter mutations [11,12]. This evidence concerns the gene IDH2 and central nervous system cancer.